Decision tool for people considering breast reconstruction surgery.
Official title: Breast Reconstruction Decision Aid (RECONJOINT)
Run by Memorial Sloan Kettering Cancer Center · NCT07335354 · Data updated 2026-11-12
Researchers will try a decision tool called RECONJOINT to help adults with breast cancer or a genetic predisposition decide about post-mastectomy breast reconstruction.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 131 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Locations | 9 sites (Basking Ridge, New Jersey and 8 other locations) |
| Status | Recruiting |
| Started | January 5, 2026 |
| Main results expected | January 5, 2029 |
| Study ends | January 5, 2029 |
| Registry record updated | July 9, 2026 |
| Trial ID | NCT07335354 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with breast cancer or a known genetic predisposition who are considering post-mastectomy breast reconstruction and have a plastic surgery consultation scheduled are ideal candidates.
✕Probably not a fit
People who are not considering post-mastectomy reconstruction or who cannot participate in English are unlikely to receive benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a feasibility project using the RECONJOINT decision aid with both focus groups and a small randomized pilot to determine if a larger trial is practical. Adult patients with a diagnosis of breast cancer or a genetic predisposition who are considering post-mastectomy reconstruction and have a scheduled plastic surgery consultation are eligible to participate. The study will enroll patient focus groups and randomize eligible patients to receive the decision aid versus usual care, tracking recruitment, retention, acceptability, and preliminary decision-related outcomes. Plastic surgeons who perform breast reconstruction frequently will also be enrolled to gather clinician perspectives on using the tool.
Why it matters
Potential benefit: If successful, the tool could help people better understand reconstruction options and feel more confident and satisfied with their decisions.
How similar studies have gone: Decision aids for surgical choices, including some work in breast reconstruction, have improved patient knowledge and reduced decisional conflict, although RECONJOINT itself is being tested here for feasibility.
Who can join: the full rules
Show full inclusion / exclusion criteria
Participant Inclusion Criteria Focus Group Participants * A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record * ≥18 years old * Considering post-mastectomy breast reconstruction RCT Participants (Patients) * A diagnosed genetic predisposition to breast cancer or a diagnosis of ductal carcinoma in situ or any invasive cancer confirmed through review of the medical record * ≥18 years old * Considering post-mastectomy breast reconstruction * Have an appointment scheduled for consultation with a plastic surgery provider RCT Participants (Physicians) * Provides breast reconstruction care ≥ 50% of the time. This is defined as over half of the surgeon's cases in the preceding calendar year being related to breast reconstruction surgery. Participant Exclusion Criteria Focus Group Participants * Not considering post-mastectomy breast reconstruction * Non-English proficiency RCT Participants (Patients) * Not considering postmastectomy breast reconstruction * Recurrent or metastatic breast cancer * Male sex * Non-English proficiency RCT Participants (Physicians) * Does not provide breast reconstruction care at least 50% of the time * Non-English proficiency
Where it's running
-
Memorial Sloan Kettering Basking Ridge
Basking Ridge, New Jersey, United States Recruiting -
Memorial Sloan Kettering Monmouth
Middletown, New Jersey, United States Recruiting -
Memorial Sloan Kettering Bergen
Montvale, New Jersey, United States Recruiting -
Memorial Sloan Kettering Commack
Commack, New York, United States Recruiting -
Memorial Sloan Kettering Westchester
Harrison, New York, United States Recruiting -
Memorial Sloan Kettering Cancer Center
New York, New York, United States Recruiting
Show 3 more locations
-
Memorial Sloan Kettering Nassau
Rockville Centre, New York, United States Recruiting -
Duke Cancer Institute (Data collection only)
Durham, North Carolina, United States Recruiting -
Duke Cancer Institute (Data collection only)
Durham, North Carolina, United States Not yet recruiting
Study contacts
- Principal investigator: Evan Matros, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Evan Matros, MD
- Email: matrose@mskcc.org
- Phone: 646-608-8044
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gyrotonic exercise for elders with breast cancer and Behcet disease
We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.
-
PECS II vs SPSIP nerve blocks for pain after mastectomy
This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.
-
CG-7321: a first-in-human test in advanced solid tumors
We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.
-
Compare a new endoscopy-assisted breast-conserving surgery with the usual approach
This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy
This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.